ApprovalTrail

Approval · Notice of Compliance 5062 · 1995

OMNIPAQUE: Notice of Compliance 5062

Issued July 31, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5062
Date
July 31, 1995
Company
Nycomed Imaging A.S.Oslo, Saone Et Loire, Norway
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Non-ionic radiographic contrast medium

Products in this notice

BrandDINStatus today
OMNIPAQUE02172720Cancelled Post Market
OMNIPAQUE02172739Marketed
OMNIPAQUE02172747Marketed
OMNIPAQUE02172755Marketed

Medicinal ingredients